Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Georges

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Hematology|November 15, 2002
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseasesGeorge E Georges, Michael Maris, Brenda M Sandmaier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantationR A Nash, M Yunosov, K Abrams, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
JAMA Neurology|December 30, 2014
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportRichard A Nash, George J Hutton, Michael K Racke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemiaDaniella M B Kerbauy, Theodore A Gooley, George E Sale, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2019
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow TransplantationJeffrey A Cohen, Laura E Baldassari, Harold L Atkins, et al.
Blood|August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosisH Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Blood|May 24, 2003
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosisRichard A Nash, James D Bowen, Peter A McSweeney, et al.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
JAMA|November 3, 2011
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignanciesMohamed L Sorror, Brenda M Sandmaier, Barry E Storer, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Hematology|November 15, 2002
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseasesGeorge E Georges, Michael Maris, Brenda M Sandmaier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantationR A Nash, M Yunosov, K Abrams, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
JAMA Neurology|December 30, 2014
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportRichard A Nash, George J Hutton, Michael K Racke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemiaDaniella M B Kerbauy, Theodore A Gooley, George E Sale, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2019
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow TransplantationJeffrey A Cohen, Laura E Baldassari, Harold L Atkins, et al.
Blood|August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosisH Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Blood|May 24, 2003
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosisRichard A Nash, James D Bowen, Peter A McSweeney, et al.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
JAMA|November 3, 2011
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignanciesMohamed L Sorror, Brenda M Sandmaier, Barry E Storer, et al.
Pageof 14